Providing care for pediatric cancer patients in the COVID‐19 era: Rapid response recommendations from a developing country
Open Access
- 15 June 2020
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (8), e28467
- https://doi.org/10.1002/pbc.28467
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude GlobalPediatric Blood & Cancer, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 TrialJournal of Clinical Oncology, 2013
- No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back‐bone therapyPediatric Blood & Cancer, 2011
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialThe Lancet Oncology, 2010